arecoline has been researched along with pyrazolanthrone in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, HM; Cheng, SJ; Chiang, CP; Deng, YT; Kuo, MY | 1 |
| Chang, LS; Chen, YJ | 1 |
2 other study(ies) available for arecoline and pyrazolanthrone
| Article | Year |
|---|---|
Arecoline-stimulated connective tissue growth factor production in human buccal mucosal fibroblasts: Modulation by curcumin.
Topics: Anthracenes; Anti-Inflammatory Agents, Non-Steroidal; Arecoline; Cheek; Cholinergic Agonists; Connective Tissue Growth Factor; Curcumin; Endothelial Cells; Epithelial Cells; Fibroblasts; Flavonoids; Humans; Imidazoles; Mouth Mucosa; Nitriles; Oral Submucous Fibrosis; Pyridines; Sulfones | 2009 |
Arecoline-induced death of human leukemia K562 cells is associated with surface up-modulation of TNFR2.
Topics: ADAM Proteins; Anthracenes; Arecoline; Calcium; Cell Death; Chelating Agents; Cholinergic Agonists; Egtazic Acid; Extracellular Signal-Regulated MAP Kinases; Humans; JNK Mitogen-Activated Protein Kinases; K562 Cells; MAP Kinase Kinase 1; MAP Kinase Signaling System; Receptors, Tumor Necrosis Factor, Type I; Receptors, Tumor Necrosis Factor, Type II; RNA Interference; Tumor Necrosis Factor-alpha; Up-Regulation | 2012 |